Characterization of cross‐reactive monoclonal antibodies against SARS‐CoV‐1 and SARS‐CoV‐2: Implication for rational design and development of pan‐sarbecovirus vaccines and neutralizing antibodies
Characterization of cross‐reactive monoclonal antibodies against SARS‐CoV‐1 and SARS‐CoV‐2: Implication for rational design and development of pan‐sarbecovirus vaccines and neutralizing antibodies
复制标题
DOI：
10.1002/jmv.28440
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Le
中科院分区：
文献类型：
--
作者：
Shibo Li;Jianbo Wu;Weiyu Jiang;Haiyan He;Yunjiao Zhou;Wei Wu;Yidan Gao;Minxiang Xie;Anqi Xia;Jiaying He;Qianqian Zhang;Yuru Han;Nan Wang;Guangqi Zhu;Qiujing Wang;Zheen Zhang;Christian T Mayer;Kang Wang;Xiangxi Wang;Junqing Wang;Zhenguo Chen;Shibo Jiang;Le
